Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Prescription of Lipid-Lowering and Antihypertensive Drugs following Pictorial Information about Subclinical Atherosclerosis: A Secondary Outcome of a Randomized Clinical Trial
Umeå universitet, Medicinska fakulteten, Institutionen för folkhälsa och klinisk medicin, Avdelningen för medicin.ORCID-id: 0000-0002-8364-6290
Umeå universitet, Medicinska fakulteten, Institutionen för folkhälsa och klinisk medicin, Avdelningen för medicin.
Umeå universitet, Medicinska fakulteten, Institutionen för folkhälsa och klinisk medicin, Avdelningen för medicin.ORCID-id: 0000-0003-2475-7131
Umeå universitet, Medicinska fakulteten, Institutionen för folkhälsa och klinisk medicin, Avdelningen för medicin. (Arcum)
Visa övriga samt affilieringar
2021 (Engelska)Ingår i: JAMA Network Open, E-ISSN 2574-3805, Vol. 4, nr 8, artikel-id e21683Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Importance: Preventive drugs are often underused. Carotid intima-media thickness and carotid plaques are associated with cardiovascular disease (CVD), and their detection could possibly improve estimation of the likelihood of CVD and prescription of preventive drugs.

Objective: To evaluate whether pictorial information on participants' asymptomatic atherosclerosis based on carotid ultrasonographic examinations to participants and their physicians had an effect on prescribing of lipid-lowering or antihypertensive drugs during the following 465 days.

Design, Setting, and Participants: Visualization of Asymptomatic Atherosclerotic Disease for Optimum Cardiovascular Prevention is a pragmatic randomized clinical trial nested within the Västerbotten Intervention Program, a CVD screening and prevention program in Sweden with 60% to 70% participation rates and small social selection bias. A total of 4177 individuals aged 40, 50, or 60 years participating in the Västerbotten Intervention Program who had low to moderate risk of CVD were invited to enroll in this trial from April 29, 2013, to June 7, 2016. Prescriptions for all participants were monitored for 465 days after the intervention. Data analysis was conducted from December 6, 2019, to April 2, 2020.

Interventions: Participants and their family physicians were randomly assigned 1:1 to receive or not receive pictorial information from carotid ultrasonographic determination of vascular age, assessed as carotid intima-media thickness and the presence of carotid plaques, combined with a follow-up call to participants by nurses.

Main Outcomes and Measures: Two outcome measures of prescriptions of antihypertensive and lipid-lowering drugs within 465 days after ultrasonography was performed. Data obtained through intention-to-treat analysis are presented as proportions of individuals with a prescription among those who had no baseline prescription for agents from these drug classes.

Results: Of the 4177 individuals invited to enroll, 3532 participants were randomized and included in the analysis; 1870 (52.9%) were women, 2278 (64.5%) were aged 60 years, 978 (27.7%) were 50 years, and 276 (7.8%) were 40 years. First prescriptions of lipid-lowering drugs were higher in the intervention group vs the control group among men (118 of 639 [18.5%] vs 38 of 692 [5.5%]; P <.001) and women (126 of 804 [15.5%] vs 38 of 817 [4.7%]; P <.001). There were no significant differences in the proportion with prescription of antihypertensive drugs in the intervention vs control groups after ultrasonography among men (58 of 482 [12.0%] vs 56 of 528 [10.6%]; P =.47) and women (60 of 612 [9.8%] vs 64 of 615 [10.4%]; P =.73).

Conclusions and Relevance: The findings of this trial demonstrate that provision of pictorial information on vascular age and carotid plaques based on the results of ultrasonographic examination increased physician prescription of lipid-lowering drugs but not antihypertensive drugs within the following 465 days.

Ort, förlag, år, upplaga, sidor
American Medical Association , 2021. Vol. 4, nr 8, artikel-id e21683
Nationell ämneskategori
Kardiologi och kardiovaskulära sjukdomar Samhällsfarmaci och klinisk farmaci
Identifikatorer
URN: urn:nbn:se:umu:diva-187088DOI: 10.1001/jamanetworkopen.2021.21683ISI: 000686734700006Scopus ID: 2-s2.0-85113325271OAI: oai:DiVA.org:umu-187088DiVA, id: diva2:1590657
Tillgänglig från: 2021-09-03 Skapad: 2021-09-03 Senast uppdaterad: 2025-02-10Bibliografiskt granskad

Open Access i DiVA

fulltext(1268 kB)212 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 1268 kBChecksumma SHA-512
682149c0b1682b4d72dcaeed52aac182dc015d2b83b34a5214abaa61c8d0d9169ec5c3bd9df25f0e2df0c4b1c1707139d4b7f7398e38635fe98816908c7cb52e
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextScopus

Person

Sjölander, MariaCarlberg, BoNorberg, MargaretaNäslund, UlfNg, Nawi

Sök vidare i DiVA

Av författaren/redaktören
Sjölander, MariaCarlberg, BoNorberg, MargaretaNäslund, UlfNg, Nawi
Av organisationen
Avdelningen för medicinInstitutionen för epidemiologi och global hälsa
I samma tidskrift
JAMA Network Open
Kardiologi och kardiovaskulära sjukdomarSamhällsfarmaci och klinisk farmaci

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 212 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
urn-nbn

Altmetricpoäng

doi
urn-nbn
Totalt: 460 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf